TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination

V Pulko, X Liu, CJ Krco, KJ Harris, X Frigola… - The Journal of …, 2009 - journals.aai.org
Agonists of TLR have been explored as vaccine adjuvants for tumor immunotherapy.
However, their immunological consequences are not fully understood. Although TLR …

TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination

V Pulko, X Liu, CJ Krco, KJ Harris… - Journal of …, 2009 - mayoclinic.elsevierpure.com
Agonists of TLR have been explored as vaccine adjuvants for tumor immunotherapy.
However, their immunological consequences are not fully understood. Although TLR …

[PDF][PDF] TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination

V Pulko, X Liu, CJ Krco, KJ Harris, X Frigola, ED Kwon… - 2009 - researchgate.net
Agonists of TLR have been explored as vaccine adjuvants for tumor immunotherapy.
However, their immunological consequences are not fully understood. Although TLR …

[HTML][HTML] TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination

V Pulko, X Liu, CJ Krco, KJ Harris… - … (Baltimore, Md.: 1950 …, 2009 - ncbi.nlm.nih.gov
Agonists of TLR have been explored as vaccine adjuvants for tumor immunotherapy.
However, their immunological consequences are not fully understood. Although TLR …

TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination.

V Pulko, X Liu, CJ Krco, KJ Harris, X Frigola… - … (Baltimore, Md.: 1950 …, 2009 - europepmc.org
Agonists of TLR have been explored as vaccine adjuvants for tumor immunotherapy.
However, their immunological consequences are not fully understood. Although TLR …

TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination

V Pulko, X Liu, CJ Krco, KJ Harris, X Frigola… - The Journal of …, 2009 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Agonists of TLR have been explored as
vaccine adjuvants for tumor immunotherapy. However, their immunological consequences …

TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination

V Pulko, X Liu, CJ Krco, KJ Harris, X Frigola… - The Journal of …, 2009 - journals.aai.org
Agonists of TLR have been explored as vaccine adjuvants for tumor immunotherapy.
However, their immunological consequences are not fully understood. Although TLR …

TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination

V Pulko, X Liu, CJ Krco, KJ Harris… - Journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
Agonists of TLR have been explored as vaccine adjuvants for tumor immunotherapy.
However, their immunological consequences are not fully understood. Although TLR …

TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination.

V Pulko, X Liu, CJ Krco, KJ Harris, X Frigola… - … (Baltimore, Md.: 1950 …, 2009 - europepmc.org
Agonists of TLR have been explored as vaccine adjuvants for tumor immunotherapy.
However, their immunological consequences are not fully understood. Although TLR …

[引用][C] TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination

V PULKO, XIN LIU, CJ KRCO… - The Journal of …, 2009 - American Association of …